Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol.

Bekelman JE, Lu H, Pugh S, Baker K, Berg CD, de Gonzalez AB, Braunstein LZ, Bosch W, Chauhan C, Ellenberg S, Fang LC, Freedman GM, Hahn EA, Haffty BG, Khan AJ, Jimenez RB, Kesslering C, Ky B, Lee C, Lu HM, Mishra MV, Mullins CD, Mutter RW, Nagda S, Pankuch M, Powell SN, Prior FW, Schupak K, Taghian AG, Wilkinson JB, MacDonald SM, Cahlon O; RadComp (Radiotherapy Comparative Effectiveness Consortium).

BMJ Open. 2019 Oct 15;9(10):e025556. doi: 10.1136/bmjopen-2018-025556.

2.

Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.

Bansal N, Zelnick L, Shlipak MG, Anderson A, Christenson R, Deo R, Defilippi C, Feldman H, Lash J, He J, Kusek J, Ky B, Seliger S, Soliman EZ, Go AS; CRIC Study Investigators.

Clin Chem. 2019 Oct 2. pii: clinchem.2019.305797. doi: 10.1373/clinchem.2019.305797. [Epub ahead of print]

PMID:
31578216
3.

Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy.

Upshaw JN, Finkelman B, Hubbard RA, Smith AM, Narayan HK, Arndt L, Domchek S, DeMichele A, Fox K, Shah P, Clark A, Bradbury A, Matro J, Adusumalli S, Carver JR, Ky B.

JACC Cardiovasc Imaging. 2019 Sep 12. pii: S1936-878X(19)30729-6. doi: 10.1016/j.jcmg.2019.07.018. [Epub ahead of print]

PMID:
31542526
4.

Persistent cardiac dysfunction on echocardiography in African American women with severe preeclampsia.

Levine LD, Lewey J, Koelper N, Downes KL, Arany Z, Elovitz MA, Sammel MD, Ky B.

Pregnancy Hypertens. 2019 Jul;17:127-132. doi: 10.1016/j.preghy.2019.05.021. Epub 2019 May 30.

PMID:
31487629
5.

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.

Gullo G, J Eustace A, Canonici A, M Collins D, Kennedy MJ, Grogan L, Breathhnach O, McCaffrey J, Keane M, Martin MJ, Gupta R, Leonard G, O'Connor M, Calvert PM, Donnellan P, Walshe J, McDermott E, Scott K, Hernando A, Parker I, W Murray D, C O'Farrell A, Maratha A, Dicker P, Rafferty M, Murphy V, O'Donovan N, M Gallagher W, Ky B, Tryfonopoulos D, Moulton B, T Byrne A, Crown J.

Ther Adv Med Oncol. 2019 Jul 24;11:1758835919864236. doi: 10.1177/1758835919864236. eCollection 2019.

6.

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.

Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, Shafi T, Go AS, Bansal N; CRIC Study Investigators.

J Am Heart Assoc. 2019 Aug 6;8(15):e012200. doi: 10.1161/JAHA.119.012200. Epub 2019 Aug 5.

7.

Dexrazoxane preferentially mitigates doxorubicin cardiotoxicity in female children with sarcoma.

Narayan HK, Putt ME, Kosaraju N, Paz A, Bhatt S, Plappert T, Mercer-Rosa L, Armenian SH, Desai AV, Womer RB, Ky B.

Open Heart. 2019 Jun 24;6(1):e001025. doi: 10.1136/openhrt-2019-001025. eCollection 2019.

8.

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.

Cornell RF, Ky B, Weiss BM, Dahm CN, Gupta DK, Du L, Carver JR, Cohen AD, Engelhardt BG, Garfall AL, Goodman SA, Harrell SL, Kassim AA, Jadhav T, Jagasia M, Moslehi J, O'Quinn R, Savona MR, Slosky D, Smith A, Stadtmauer EA, Vogl DT, Waxman A, Lenihan D.

J Clin Oncol. 2019 Aug 1;37(22):1946-1955. doi: 10.1200/JCO.19.00231. Epub 2019 Jun 12.

PMID:
31188726
9.

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.

Upshaw JN, Ruthazer R, Miller KD, Parsons SK, Erban JK, O'Neill AM, Demissei B, Sledge G, Wagner L, Ky B, Kent DM.

Clin Breast Cancer. 2019 Aug;19(4):259-267.e1. doi: 10.1016/j.clbc.2019.04.012. Epub 2019 May 2.

PMID:
31175052
10.

Cardiovascular toxicities of therapy for genitourinary malignancies.

Narayan V, Vaughn DJ, Ky B.

Urol Oncol. 2019 May 16. pii: S1078-1439(19)30185-1. doi: 10.1016/j.urolonc.2019.04.029. [Epub ahead of print] Review.

PMID:
31104977
11.

Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week.

Hayek SS, Ganatra S, Lenneman C, Scherrer-Crosbie M, Leja M, Lenihan DJ, Yang E, Ryan TD, Liu J, Carver J, Mousavi N, O'Quinn R, Arnold A, Banchs J, Barac A, Ky B.

J Am Coll Cardiol. 2019 May 7;73(17):2226-2235. doi: 10.1016/j.jacc.2019.02.041. Review.

12.

Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy.

Demissei BG, Finkelman BS, Hubbard RA, Zhang L, Smith AM, Sheline K, McDonald C, Narayan HK, Narayan V, Waxman AJ, Domchek SM, DeMichele A, Shah P, Clark AS, Bradbury AR, Carver JR, Upshaw J, Armenian SH, Liu P, Ky B.

Cancer. 2019 Aug 15;125(16):2762-2771. doi: 10.1002/cncr.32149. Epub 2019 May 1.

PMID:
31042319
13.

Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy.

Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, Lunde IG, Wakimoto H, Smith AM, Toepfer CN, Getz K, Gorham J, Patel P, Ito K, Willcox JA, Arany Z, Li J, Owens AT, Govind R, Nuñez B, Mazaika E, Bayes-Genis A, Walsh R, Finkelman B, Lupon J, Whiffin N, Serrano I, Midwinter W, Wilk A, Bardaji A, Ingold N, Buchan R, Tayal U, Pascual-Figal DA, de Marvao A, Ahmad M, Garcia-Pinilla JM, Pantazis A, Dominguez F, John Baksi A, O'Regan DP, Rosen SD, Prasad SK, Lara-Pezzi E, Provencio M, Lyon AR, Alonso-Pulpon L, Cook SA, DePalma SR, Barton PJR, Aplenc R, Seidman JG, Ky B, Ware JS, Seidman CE.

Circulation. 2019 Jul 2;140(1):31-41. doi: 10.1161/CIRCULATIONAHA.118.037934. Epub 2019 Apr 16.

14.

Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey.

Psotka MA, Ammon SE, Fiuzat M, Bozkurt B, Chung ES, Cole RT, Greene SJ, Kraus D, Ky B, McIlvennan CK, Shah P, Teerlink JR, Walsh MN, Jessup M, O'Connor CM.

JACC Heart Fail. 2019 May;7(5):431-438. doi: 10.1016/j.jchf.2019.02.008. Epub 2019 Apr 10.

PMID:
30981742
15.

Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity.

Padegimas A, Clasen S, Ky B.

Trends Cardiovasc Med. 2019 Jan 29. pii: S1050-1738(19)30006-4. doi: 10.1016/j.tcm.2019.01.006. [Epub ahead of print] Review.

PMID:
30745071
16.

Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer.

Schaffer K, Panneerselvam N, Loh KP, Herrmann R, Kleckner IR, Dunne RF, Lin PJ, Heckler CE, Gerbino N, Bruckner LB, Storozynsky E, Ky B, Baran A, Mohile SG, Mustian KM, Fung C.

J Natl Compr Canc Netw. 2019 Jan;17(1):57-63. doi: 10.6004/jnccn.2018.7082.

PMID:
30659130
17.

Precision Cardio-Oncology.

Dreyfuss AD, Bravo PE, Koumenis C, Ky B.

J Nucl Med. 2019 Apr;60(4):443-450. doi: 10.2967/jnumed.118.220137. Epub 2019 Jan 17.

18.

Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer Therapy.

Demissei BG, Finkelman BS, Hubbard RA, Smith AM, Narayan HK, Narayan V, Shah P, Waxman AJ, Domchek SM, Ky B.

J Am Coll Cardiol. 2019 Jan 22;73(2):248-249. doi: 10.1016/j.jacc.2018.10.057. No abstract available.

19.

Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma.

Demissei BG, Freedman G, Feigenberg SJ, Plastaras JP, Maity A, Smith AM, McDonald C, Sheline K, Simone CB 2nd, Lin LL, Carver JR, Liu P, Zhang L, Bekelman JE, Ky B.

Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):851-860. doi: 10.1016/j.ijrobp.2018.11.013. Epub 2018 Nov 14.

PMID:
30445173
20.

Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group.

Getz KD, Sung L, Ky B, Gerbing RB, Leger KJ, Leahy AB, Sack L, Woods WG, Alonzo T, Gamis A, Aplenc R.

J Clin Oncol. 2019 Jan 1;37(1):12-21. doi: 10.1200/JCO.18.00313. Epub 2018 Oct 31.

PMID:
30379624
21.

Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.

Upshaw JN, O'Neill A, Carver JR, Dimond EP, Denlinger CS, Kircher SM, Wagner LI, Ky B, Brell JM.

Clin Colorectal Cancer. 2019 Mar;18(1):44-51. doi: 10.1016/j.clcc.2018.08.001. Epub 2018 Aug 20.

PMID:
30348619
22.

Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer.

Brown JC, Rhim AD, Manning SL, Brennan L, Mansour AI, Rustgi AK, Damjanov N, Troxel AB, Rickels MR, Ky B, Zemel BS, Courneya KS, Schmitz KH.

PLoS One. 2018 Oct 17;13(10):e0204875. doi: 10.1371/journal.pone.0204875. eCollection 2018.

23.

Diastolic dysfunction in tetralogy of Fallot: Comparison of echocardiography with catheterization.

DiLorenzo M, Hwang WT, Goldmuntz E, Ky B, Mercer-Rosa L.

Echocardiography. 2018 Oct;35(10):1641-1648. doi: 10.1111/echo.14113. Epub 2018 Aug 13.

24.

Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model.

Truitt R, Mu A, Corbin EA, Vite A, Brandimarto J, Ky B, Margulies KB.

JACC Basic Transl Sci. 2018 May 30;3(2):265-276. doi: 10.1016/j.jacbts.2017.12.007. eCollection 2018 Apr.

25.

Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention.

Armenian SH, Armstrong GT, Aune G, Chow EJ, Ehrhardt MJ, Ky B, Moslehi J, Mulrooney DA, Nathan PC, Ryan TD, van der Pal HJ, van Dalen EC, Kremer LCM.

J Clin Oncol. 2018 Jul 20;36(21):2135-2144. doi: 10.1200/JCO.2017.76.3920. Epub 2018 Jun 6. Review.

PMID:
29874141
26.

Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma.

Catino AB, Hubbard RA, Chirinos JA, Townsend R, Keefe S, Haas NB, Puzanov I, Fang JC, Agarwal N, Hyman D, Smith AM, Gordon M, Plappert T, Englefield V, Narayan V, Ewer S, ElAmm C, Lenihan D, Ky B.

Circ Heart Fail. 2018 Mar;11(3):e004408. doi: 10.1161/CIRCHEARTFAILURE.117.004408.

27.

Priorities in the Cardiovascular Care of Breast Cancer Survivors.

Ky B.

J Oncol Pract. 2018 Apr;14(4):205-211. doi: 10.1200/JOP.18.00027.

PMID:
29641951
28.

Longitudinal Changes in Right Ventricular Function in Tetralogy of Fallot in the Initial Years after Surgical Repair.

DiLorenzo MP, Elci OU, Wang Y, Banerjee A, Sato T, Ky B, Goldmuntz E, Mercer-Rosa L.

J Am Soc Echocardiogr. 2018 Jul;31(7):816-821. doi: 10.1016/j.echo.2018.02.013. Epub 2018 Apr 4.

29.

Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction.

Zhang KW, Finkelman BS, Gulati G, Narayan HK, Upshaw J, Narayan V, Plappert T, Englefield V, Smith AM, Zhang C, Hundley WG, Ky B.

JACC Cardiovasc Imaging. 2018 Aug;11(8):1059-1068. doi: 10.1016/j.jcmg.2018.01.015. Epub 2018 Mar 14.

30.

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.

Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Piña IL, Volgman AS; American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research.

Circulation. 2018 Feb 20;137(8):e30-e66. doi: 10.1161/CIR.0000000000000556. Epub 2018 Feb 1. Erratum in: Circulation. 2019 Aug 27;140(9):e543.

31.

Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.

Narayan V, Ky B.

Annu Rev Med. 2018 Jan 29;69:97-111. doi: 10.1146/annurev-med-041316-090622. Review.

32.

Echocardiography Core Laboratory Reproducibility of Cardiac Safety Assessments in Cardio-Oncology.

Khouri MG, Ky B, Dunn G, Plappert T, Englefield V, Rabineau D, Yow E, Barnhart HX, St John Sutton M, Douglas PS.

J Am Soc Echocardiogr. 2018 Mar;31(3):361-371.e3. doi: 10.1016/j.echo.2017.11.018. Epub 2018 Feb 2.

33.

A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors.

Brown JC, Damjanov N, Courneya KS, Troxel AB, Zemel BS, Rickels MR, Ky B, Rhim AD, Rustgi AK, Schmitz KH.

Psychooncology. 2018 Apr;27(4):1221-1228. doi: 10.1002/pon.4655. Epub 2018 Feb 20.

34.

Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management.

Grisham R, Ky B, Tewari KS, Chaplin DJ, Walker J.

Gynecol Oncol Res Pract. 2018 Jan 5;5:1. doi: 10.1186/s40661-017-0058-5. eCollection 2018. Review.

35.

Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm.

Clasen SC, Ky B, O'Quinn R, Giantonio B, Teitelbaum U, Carver JR.

J Gastrointest Oncol. 2017 Dec;8(6):970-979. doi: 10.21037/jgo.2017.09.07.

36.

Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis.

Waxman AJ, Clasen S, Hwang WT, Garfall A, Vogl DT, Carver J, O'Quinn R, Cohen AD, Stadtmauer EA, Ky B, Weiss BM.

JAMA Oncol. 2018 Mar 8;4(3):e174519. doi: 10.1001/jamaoncol.2017.4519. Epub 2018 Mar 8.

37.

Reply: Statistical Analyses of Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction.

Putt M, Finkelman BS, Ky B.

J Am Coll Cardiol. 2017 Dec 19;70(24):3073. doi: 10.1016/j.jacc.2017.09.1141. No abstract available.

38.

Contrast-Enhanced Echocardiography Has the Greatest Impact in Patients with Reduced Ejection Fractions.

Zhao H, O'Quinn R, Ambrose M, Jagasia D, Ky B, Wald J, Ferrari VA, Kirkpatrick JN, Han Y.

J Am Soc Echocardiogr. 2018 Mar;31(3):289-296. doi: 10.1016/j.echo.2017.09.003. Epub 2017 Oct 27.

PMID:
29111122
39.

Dose-response effects of exercise on insulin among colon cancer survivors.

Brown JC, Rickels MR, Troxel AB, Zemel BS, Damjanov N, Ky B, Rhim AD, Rustgi AK, Courneya KS, Schmitz KH.

Endocr Relat Cancer. 2018 Jan;25(1):11-19. doi: 10.1530/ERC-17-0377. Epub 2017 Oct 10.

40.

Dose-response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial.

Brown JC, Zemel BS, Troxel AB, Rickels MR, Damjanov N, Ky B, Rhim AD, Rustgi AK, Courneya KS, Schmitz KH.

Br J Cancer. 2017 Nov 21;117(11):1614-1620. doi: 10.1038/bjc.2017.339. Epub 2017 Sep 21.

41.

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

Finkelman BS, Putt M, Wang T, Wang L, Narayan H, Domchek S, DeMichele A, Fox K, Matro J, Shah P, Clark A, Bradbury A, Narayan V, Carver JR, Tang WHW, Ky B.

J Am Coll Cardiol. 2017 Jul 11;70(2):152-162. doi: 10.1016/j.jacc.2017.05.019. Erratum in: J Am Coll Cardiol. 2017 Nov 28;70(21):2738.

42.

Efficient Quantitative Comparisons of Plasma Proteomes Using Label-Free Analysis with MaxQuant.

Beer LA, Liu P, Ky B, Barnhart KT, Speicher DW.

Methods Mol Biol. 2017;1619:339-352. doi: 10.1007/978-1-4939-7057-5_23.

43.

Quantitative Comparisons of Large Numbers of Human Plasma Samples Using TMT10plex Labeling.

Liu P, Beer LA, Ky B, Barnhart KT, Speicher DW.

Methods Mol Biol. 2017;1619:319-337. doi: 10.1007/978-1-4939-7057-5_22.

44.

In-Depth, Reproducible Analysis of Human Plasma Using IgY 14 and SuperMix Immunodepletion.

Beer LA, Ky B, Barnhart KT, Speicher DW.

Methods Mol Biol. 2017;1619:81-101. doi: 10.1007/978-1-4939-7057-5_7.

45.

Dose-response Effects of Aerobic Exercise Among Colon Cancer Survivors: A Randomized Phase II Trial.

Brown JC, Troxel AB, Ky B, Damjanov N, Zemel BS, Rickels MR, Rhim AD, Rustgi AK, Courneya KS, Schmitz KH.

Clin Colorectal Cancer. 2018 Mar;17(1):32-40. doi: 10.1016/j.clcc.2017.06.001. Epub 2017 Jun 17.

46.

Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults.

Wells QS, Veatch OJ, Fessel JP, Joon AY, Levinson RT, Mosley JD, Held EP, Lindsay CS, Shaffer CM, Weeke PE, Glazer AM, Bersell KR, Van Driest SL, Karnes JH, Blair MA, Lagrone LW, Su YR, Bowton EA, Feng Z, Ky B, Lenihan DJ, Fisch MJ, Denny JC, Roden DM.

Pharmacogenet Genomics. 2017 Jul;27(7):247-254. doi: 10.1097/FPC.0000000000000284.

47.

Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma.

Narayan V, Keefe S, Haas N, Wang L, Puzanov I, Putt M, Catino A, Fang J, Agarwal N, Hyman D, Smith AM, Finkelman BS, Narayan HK, Ewer S, ElAmm C, Lenihan D, Ky B.

Clin Cancer Res. 2017 Jul 15;23(14):3601-3609. doi: 10.1158/1078-0432.CCR-16-2869. Epub 2017 Feb 14.

48.

A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate.

O'Farrell AC, Evans R, Silvola JM, Miller IS, Conroy E, Hector S, Cary M, Murray DW, Jarzabek MA, Maratha A, Alamanou M, Udupi GM, Shiels L, Pallaud C, Saraste A, Liljenbäck H, Jauhiainen M, Oikonen V, Ducret A, Cutler P, McAuliffe FM, Rousseau JA, Lecomte R, Gascon S, Arany Z, Ky B, Force T, Knuuti J, Gallagher WM, Roivainen A, Byrne AT.

PLoS One. 2017 Jan 27;12(1):e0169964. doi: 10.1371/journal.pone.0169964. eCollection 2017.

49.

Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study.

Narayan HK, Wei W, Feng Z, Lenihan D, Plappert T, Englefield V, Fisch M, Ky B.

Open Heart. 2017 Jan 16;4(1):e000524. doi: 10.1136/openhrt-2016-000524. eCollection 2017.

50.

Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up.

Narayan HK, Finkelman B, French B, Plappert T, Hyman D, Smith AM, Margulies KB, Ky B.

Circulation. 2017 Apr 11;135(15):1397-1412. doi: 10.1161/CIRCULATIONAHA.116.023463. Epub 2017 Jan 19.

Supplemental Content

Support Center